Jon P. Stonehouse - 19 Dec 2023 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
President & CEO, Director
Signature
/s/ Alane P. Barnes, by power of attorney
Issuer symbol
BCRX
Transactions as of
19 Dec 2023
Net transactions value
-$85,238
Form type
4
Filing time
20 Dec 2023, 16:40:30 UTC
Previous filing
18 Dec 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Tax liability $85,238 -14,089 -1.2% $6.05 1,114,770 19 Dec 2023 Direct F1
holding BCRX Common Stock 10,000 19 Dec 2023 By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust
holding BCRX Common Stock 10,000 19 Dec 2023 By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.